Thompson Davis & Co’s Anterix ATEX Stock Holding History

Thompson Davis & Co’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-125	Closed	-$4K	–	667
2018 Q1	$4K	Sell	125 -350	-74%	-$11.7K	0.01%	508
2017 Q4	$15K	Buy	475 +350	+280%	+$11.3K	0.04%	354
2017 Q3	$4K	Buy	+125	New	+$3.42K	0.01%	879

Other funds holding ATEX

Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Thompson Davis & Co's ATEX Position: Q2 2018 in Review

Thompson Davis & Co sold out of Anterix (ATEX) in Q2 2018, closing a stake of 125 shares — an estimated $4K sold.

Thompson Davis & Co first reported a position in ATEX in Q3 2017 and held it in 3 quarters. The position peaked at $15K in Q4 2017. 52 funds tracked by Wall St. Rank hold ATEX as of Q2 2018.

Thompson Davis & Co reported no remaining Anterix position as of Q2 2018 after selling out during the quarter.
Thompson Davis & Co sold 125 Anterix shares in Q2 2018, an estimated $4K.
Thompson Davis & Co first reported a position in Anterix in Q3 2017 and held it in 3 quarters.
Thompson Davis & Co's Anterix position peaked at $15K in Q4 2017.
52 funds tracked by Wall St. Rank held Anterix as of Q2 2018.

Based on Thompson Davis & Co's 13F filing for Q2 2018, filed 3 Aug 2018.